Therapy options for chronic lung allograft dysfunction–bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review-Reference-Cited by-同舟云学术

Therapy options for chronic lung allograft dysfunction–bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review

Published:2017-09 Issue:9 Volume:36 Page:921-933
ISSN:1053-2498
Container-title:The Journal of Heart and Lung Transplantation
language:en
Short-container-title:The Journal of Heart and Lung Transplantation

Author:

Benden Christian,Haughton Maria^ORCID,Leonard Saoirse,Huber Lars C.

Publisher

Elsevier BV

Subject

Transplantation,Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference43 articles.

1. The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult lung and heart-lung transplantation report 2014-2015; focus theme: early graft failure;Yusen;J Heart Lung Transplant,2015

2. A new classification system for chronic lung allograft dysfunction;Verleden;J Heart Lung Transplant,2014

3. Interstitial and airspace granulation tissue reactions in lung transplant recipients;Yousem;Am J Surg Pathol,1992

4. Bronchiolitis obliterans after human lung transplantation;Estenne;Am J Respir Crit Care Med,2002

5. Immunosuppression in lung transplantation;Scheffert;J Thorac Dis,2014

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ethical considerations in lung re-transplantation;Current Opinion in Organ Transplantation;2024-08-07

2. A novel web-based tool for lung transplant patients undergoing extracorporeal photopheresis;JHLT Open;2024-08

3. Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis;Journal of Translational Medicine;2024-03-14

4. A review of the therapeutic potential of the cysteinyl leukotriene antagonist Montelukast in the treatment of bronchiolitis obliterans syndrome following lung and hematopoietic-stem cell transplantation and its possible mechanisms;Therapeutic Advances in Respiratory Disease;2024-01

5. Telocytes protect against lung tissue fibrosis through hexokinase 2‐dependent pathway by secreting hepatocyte growth factor;Clinical and Experimental Pharmacology and Physiology;2023-09-16